BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12391198)

  • 1. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.
    Zaldumbide A; Carlotti F; Pognonec P; Boulukos KE
    J Immunol; 2002 Nov; 169(9):4873-81. PubMed ID: 12391198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes.
    Wang W; Wykrzykowska J; Johnson T; Sen R; Sen J
    J Immunol; 1999 Jan; 162(1):314-22. PubMed ID: 9886401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion.
    Staal FJ; Weerkamp F; Baert MR; van den Burg CM; van Noort M; de Haas EF; van Dongen JJ
    J Immunol; 2004 Jan; 172(2):1099-108. PubMed ID: 14707084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
    Xi H; Kersh GJ
    J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes.
    Norment AM; Bogatzki LY; Klinger M; Ojala EW; Bevan MJ; Kay RJ
    J Immunol; 2003 Feb; 170(3):1141-9. PubMed ID: 12538669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation.
    Na SY; Patra A; Scheuring Y; Marx A; Tolaini M; Kioussis D; Hemmings BA; Hünig T; Bommhardt U
    J Immunol; 2003 Aug; 171(3):1285-96. PubMed ID: 12874217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.
    Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW
    J Immunol; 2001 Jul; 167(2):715-23. PubMed ID: 11441075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
    Heinly CS; Sempowski GD; Lee DM; Patel DD; McDermott PM; Scearce RM; Thompson CB; Haynes BF
    Int Immunol; 2001 Feb; 13(2):157-66. PubMed ID: 11157849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The requirements for Fas-associated death domain signaling in mature T cell activation and survival.
    Beisner DR; Chu IH; Arechiga AF; Hedrick SM; Walsh CM
    J Immunol; 2003 Jul; 171(1):247-56. PubMed ID: 12817005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective thymocyte maturation by transgenic expression of a truncated form of the T lymphocyte adapter molecule and Fyn substrate, Sin.
    Donlin LT; Roman CA; Adlam M; Regelmann AG; Alexandropoulos K
    J Immunol; 2002 Dec; 169(12):6900-9. PubMed ID: 12471123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
    McKean DJ; Huntoon CJ; Bell MP; Tai X; Sharrow S; Hedin KE; Conley A; Singer A
    J Immunol; 2001 Mar; 166(5):3468-75. PubMed ID: 11207305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.
    Wolvetang EJ; Wilson TJ; Sanij E; Busciglio J; Hatzistavrou T; Seth A; Hertzog PJ; Kola I
    Hum Mol Genet; 2003 Feb; 12(3):247-55. PubMed ID: 12554679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of IL-7 on early human thymocyte progenitor cells in vitro and in SCID-hu Thy/Liv mice.
    Napolitano LA; Stoddart CA; Hanley MB; Wieder E; McCune JM
    J Immunol; 2003 Jul; 171(2):645-54. PubMed ID: 12847229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment.
    Doan LL; Kitay MK; Yu Q; Singer A; Herblot S; Hoang T; Bear SE; Morse HC; Tsichlis PN; Grimes HL
    J Immunol; 2003 Mar; 170(5):2356-66. PubMed ID: 12594258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Met signalling is required for efficient postnatal thymic regeneration and repair.
    Song Y; Su M; Panchatsharam P; Rood D; Lai L
    Immunology; 2015 Feb; 144(2):245-53. PubMed ID: 25074726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell development in PU.1-deficient mice.
    Spain LM; Guerriero A; Kunjibettu S; Scott EW
    J Immunol; 1999 Sep; 163(5):2681-7. PubMed ID: 10453009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.